Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

Benedetto Bruno; Holger W. Auner; Gösta Gahrton; Laurent Garderet; Moreno Festuccia; Marco Ladetto; Roberto M. Lemoli; Massimo Massaia; Curly Morris; Antonio Palumbo; Stefan Schönland; Mario Boccadoro; Nicolaus Kröger

doi:10.3109/10428194.2015.1131278

Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

Benedetto Bruno
, Holger W. Auner
, Gösta Gahrton
, Laurent Garderet
, Moreno Festuccia
, Marco Ladetto
, Roberto M. Lemoli
, Massimo Massaia
, Curly Morris
, Antonio Palumbo
, Stefan Schönland
, Mario Boccadoro
, Nicolaus Kröger

Research output: Contribution to journal › Review article › peer-review

Abstract

The European Society for Blood and Marrow Transplantation Chronic Malignancies Working Party held a preceptorship meeting in Turin, Italy on 25-26 September 2014, to discuss the role of stem cell transplantation (SCT) in the treatment of multiple myeloma and other plasma cell disorders. Scientists and clinicians working in the field gathered to discuss a variety of topics including the results of recent clinical trials, basic research, the concept of minimal residual disease, and immune modulation. As individual presentations revealed, important advances have occurred in our understanding of the pathophysiology of myeloma and the role that SCT, along with other forms of immunotherapy, plays in treating it. Each presentation stimulated discussion and exchange of ideas among the attendants. We decided to summarize and, importantly, to update the meeting proceedings in this review to share stimulating discussions and ideas on potentially novel treatment strategies among clinicians.

Original language	English
Pages (from-to)	1256-1268
Number of pages	13
Journal	Leukemia and Lymphoma
Volume	57
Issue number	6
DOIs	https://doi.org/10.3109/10428194.2015.1131278
Publication status	Published - 2 Jun 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Multiple myeloma
new drugs
stem cell transplantation

Access to Document

10.3109/10428194.2015.1131278

Cite this

Bruno, B., Auner, H. W., Gahrton, G., Garderet, L., Festuccia, M., Ladetto, M., Lemoli, R. M., Massaia, M., Morris, C., Palumbo, A., Schönland, S., Boccadoro, M., & Kröger, N. (2016). Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting). Leukemia and Lymphoma, 57(6), 1256-1268. https://doi.org/10.3109/10428194.2015.1131278

@article{6b511a37e7b541fd9696ab735d08ed7d,

title = "Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)",

abstract = "The European Society for Blood and Marrow Transplantation Chronic Malignancies Working Party held a preceptorship meeting in Turin, Italy on 25-26 September 2014, to discuss the role of stem cell transplantation (SCT) in the treatment of multiple myeloma and other plasma cell disorders. Scientists and clinicians working in the field gathered to discuss a variety of topics including the results of recent clinical trials, basic research, the concept of minimal residual disease, and immune modulation. As individual presentations revealed, important advances have occurred in our understanding of the pathophysiology of myeloma and the role that SCT, along with other forms of immunotherapy, plays in treating it. Each presentation stimulated discussion and exchange of ideas among the attendants. We decided to summarize and, importantly, to update the meeting proceedings in this review to share stimulating discussions and ideas on potentially novel treatment strategies among clinicians.",

keywords = "Multiple myeloma, new drugs, stem cell transplantation",

author = "Benedetto Bruno and Auner, \{Holger W.\} and G{\"o}sta Gahrton and Laurent Garderet and Moreno Festuccia and Marco Ladetto and Lemoli, \{Roberto M.\} and Massimo Massaia and Curly Morris and Antonio Palumbo and Stefan Sch{\"o}nland and Mario Boccadoro and Nicolaus Kr{\"o}ger",

note = "Publisher Copyright: {\textcopyright} 2016 Taylor \& Francis.",

year = "2016",

month = jun,

day = "2",

doi = "10.3109/10428194.2015.1131278",

language = "English",

volume = "57",

pages = "1256--1268",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

Bruno, B, Auner, HW, Gahrton, G, Garderet, L, Festuccia, M, Ladetto, M, Lemoli, RM, Massaia, M, Morris, C, Palumbo, A, Schönland, S, Boccadoro, M & Kröger, N 2016, 'Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)', Leukemia and Lymphoma, vol. 57, no. 6, pp. 1256-1268. https://doi.org/10.3109/10428194.2015.1131278

TY - JOUR

T1 - Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

AU - Bruno, Benedetto

AU - Auner, Holger W.

AU - Gahrton, Gösta

AU - Garderet, Laurent

AU - Festuccia, Moreno

AU - Ladetto, Marco

AU - Lemoli, Roberto M.

AU - Massaia, Massimo

AU - Morris, Curly

AU - Palumbo, Antonio

AU - Schönland, Stefan

AU - Boccadoro, Mario

AU - Kröger, Nicolaus

PY - 2016/6/2

Y1 - 2016/6/2

N2 - The European Society for Blood and Marrow Transplantation Chronic Malignancies Working Party held a preceptorship meeting in Turin, Italy on 25-26 September 2014, to discuss the role of stem cell transplantation (SCT) in the treatment of multiple myeloma and other plasma cell disorders. Scientists and clinicians working in the field gathered to discuss a variety of topics including the results of recent clinical trials, basic research, the concept of minimal residual disease, and immune modulation. As individual presentations revealed, important advances have occurred in our understanding of the pathophysiology of myeloma and the role that SCT, along with other forms of immunotherapy, plays in treating it. Each presentation stimulated discussion and exchange of ideas among the attendants. We decided to summarize and, importantly, to update the meeting proceedings in this review to share stimulating discussions and ideas on potentially novel treatment strategies among clinicians.

AB - The European Society for Blood and Marrow Transplantation Chronic Malignancies Working Party held a preceptorship meeting in Turin, Italy on 25-26 September 2014, to discuss the role of stem cell transplantation (SCT) in the treatment of multiple myeloma and other plasma cell disorders. Scientists and clinicians working in the field gathered to discuss a variety of topics including the results of recent clinical trials, basic research, the concept of minimal residual disease, and immune modulation. As individual presentations revealed, important advances have occurred in our understanding of the pathophysiology of myeloma and the role that SCT, along with other forms of immunotherapy, plays in treating it. Each presentation stimulated discussion and exchange of ideas among the attendants. We decided to summarize and, importantly, to update the meeting proceedings in this review to share stimulating discussions and ideas on potentially novel treatment strategies among clinicians.

KW - Multiple myeloma

KW - new drugs

KW - stem cell transplantation

UR - https://www.scopus.com/pages/publications/84953271380

U2 - 10.3109/10428194.2015.1131278

DO - 10.3109/10428194.2015.1131278

M3 - Review article

SN - 1042-8194

VL - 57

SP - 1256

EP - 1268

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 6

ER -

Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this